Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01446263 · ClinicalTrials.gov registry record · Phase 3

RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial

A Phase 3 study of Vascular Access Complication, sponsored by North Texas Veterans Healthcare System.

Completed
Registry status
Phase 3
Development phase
128
Enrollment target
1
Study location

NCT01446263: Completed Phase 3 study of Vascular Access Complication, sponsored by North Texas Veterans Healthcare System.

NCT01446263 is a Phase 3 study of Vascular Access Complication that has completed, run by North Texas Veterans Healthcare System. The registered enrollment target is 128 participants, below the 735-participant average among 6 other Vascular Access Complication trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01446263, a Phase 3 study of Vascular Access Complication, has completed, sponsored by North Texas Veterans Healthcare System.

COMPLETED
Registry status
Phase 3
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

Increased use of radial access for cardiac catheterization is being advocated because studies have showed lower arterial access related complication rates and higher patient satisfaction as compared to femoral access. However, little is known on patients with prior coronary artery bypass graft (CABG). The RADIAL CABG Trial is a randomized-controlled trial proposed to test the hypothesis that bypass graft angiography and intervention via radial access provides lower vascular complication rates, similar contrast and equipment utilization and higher patient satisfaction when compared with transfemoral approach.

Interventions

  • PROCEDURE Radial access versus femoral access for coronary angiography and intervention

Study Locations (1)

Texas

  • Dallas VA Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2011-10
Est. Completion 2013-04
Phase Phase 3

What the finished NCT01446263 record still lists

NCT01446263 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 735-participant average among 6 other Vascular Access Complication trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Vascular Access Complication appearing as the primary indexed condition, and to 1 intervention - of which Radial access versus femoral access for coronary angiography and intervention is the first listed.

NCT01446263 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT01446263 about?

NCT01446263 is a clinical study titled "RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial". Increased use of radial access for cardiac catheterization is being advocated because studies have showed lower arterial access related complication rates and higher patient satisfaction as compared to femoral access. However, little is known on patients with prior coronary artery bypass graft (CABG...

What is the current status of trial NCT01446263?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 128 participants. The study started on 2011-10. Estimated completion is 2013-04.

What conditions does trial NCT01446263 study?

This clinical trial studies the following conditions: Vascular Access Complication.

What interventions are being tested in trial NCT01446263?

The interventions under investigation include: Radial access versus femoral access for coronary angiography and intervention (PROCEDURE).

Who is sponsoring clinical trial NCT01446263?

This trial is sponsored by North Texas Veterans Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01446263 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vascular Access Complication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01446263, the US trial registry maintained by the National Library of Medicine. NCT01446263 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.